logo

For the Inventor, By the Inventor

Harvard, MA, United States of America

Patricia Nell Hurter

USPTO Granted Patents = 16 


 

Average Co-Inventor Count = 9.4

ph-index = 10

Forward Citations = 477(Granted Patents)


Company Filing History:

goldMedal16 out of 1,152 
 
Vertex Pharmaceuticals, Inc.
 patents

Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 12458635 - Pharmaceutical composition and administrations thereof (2025-11-04),
2. 12214083 - Pharmaceutical composition and administrations thereof (2025-02-04),
3. 11752106 - Pharmaceutical composition and administrations thereof (2023-09-12),
4. 11564916 - Pharmaceutical composition and administrations thereof (2023-01-31),
5. 11291662 - Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2022-04-05),
6. 11147770 - Pharmaceutical composition and administrations thereof (2021-10-19),
7. 10646481 - Pharmaceutical composition and administrations thereof (2020-05-12),
8. 10537565 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2020-01-21),
9. 10272046 - Pharmaceutical composition and administrations thereof (2019-04-30),
10. 10231932 - Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases (2019-03-19),
11. 9931334 - Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2018-04-03),
12. 9670163 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2017-06-06),
13. 9139530 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2015-09-22),
14. 8883206 - Pharmaceutical composition and administrations thereof (2014-11-11),
15. 8754224 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2014-06-17),

Title: The Innovative Inventor: Patricia Nell Hurter

Introduction:

Patricia Nell Hurter is a prolific inventor based in Harvard, MA, with a remarkable track record of 14 patents to her name. Her groundbreaking work in pharmaceutical compositions has pushed the boundaries of treatment options for various medical conditions.

Latest Patents:

Hurter's latest patents focus on pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide. These formulations have paved the way for innovative methods of treating cystic fibrosis, showcasing her dedication to advancing healthcare solutions.

Career Highlights:

Currently employed at Vertex Pharmaceuticals, Inc., Hurter continues to drive innovation in the pharmaceutical industry. Her expertise in formulating solid dispersions has revolutionized drug delivery mechanisms, making treatments more effective and accessible to patients in need.

Collaborations:

Hurter's collaborative spirit is evident through her work with esteemed colleagues such as William Rowe and Christopher Young. Together, they have contributed to the development of cutting-edge pharmaceutical compositions, setting new standards for medical advancements.

Conclusion:

In conclusion, Patricia Nell Hurter stands as a trailblazing inventor whose ingenuity and commitment to improving healthcare have left a lasting impact on the industry. With 14 patents under her belt and a drive for innovation, she continues to inspire future generations of inventors in the pursuit of groundbreaking discoveries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…